Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Core One Labs Inc (OP: CLABF )

0.3275 -0.0199 (-5.73%)
Streaming Delayed Price Updated: 11:50 AM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,149
Open 0.3217
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3474
Today's Range 0.3217 - 0.3275
52wk Range 0.2200 - 0.8500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
Core One Labs' Akome Partners To Study Next-Gen Psychedelics 
Via Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? 
Via Benzinga

Performance

YTD
-44.49%
-44.49%
1 Month
-14.36%
-14.36%
3 Month
-38.21%
-38.21%
6 Month
-28.26%
-28.26%
1 Year
-55.26%
-55.26%

More News

Read More
Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
Via ACCESSWIRE
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Via Benzinga
Core One Labs' Scientists Successfully Complete Breakthrough First Step in Producing API-Grade DMT
Via ACCESSWIRE
Core One Labs' Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results
Via ACCESSWIRE
Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers
Via ACCESSWIRE
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Via Benzinga
Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada
Via Benzinga
Core One Labs’ Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in January
Via ACCESSWIRE
Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities
Via ACCESSWIRE
European University to Fund Core One Labs' Akome Advanced Neurogenesis Stimulation Studies
Via ACCESSWIRE
Core One Labs Nearing GMP Production as Canada’s Province of Alberta Announces Game Changing Legislation
Via ACCESSWIRE
Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application
Via ACCESSWIRE
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Via Benzinga
Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds
Via ACCESSWIRE
Core One Labs' Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic Potential
Via ACCESSWIRE
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Via Benzinga
Core One Rolls Out Commercial Sales Strategy for its Revolutionary API Grade Biosynthetic Psilocybin
Via ACCESSWIRE
Core One Labs Engages in Talks With GMP Manufacturing Partner for Commercial Scale Production of Proprietary Biosynthetic Psilocybin
Via ACCESSWIRE
Core One Labs' Akome Achieves Another Milestone in Development of its Psychedelic Drug Formulas and Announces Positive Results from Neuro-Pharmacokinetics Studies
Via ACCESSWIRE
Core One Labs’ Vocan Successfully Converts Psilocin Precursor into Psilocybin
Via ACCESSWIRE
Core One Labs' Subsidiaries Successfully Produce Psilocin Precursor for Production to Psilocybin
Via ACCESSWIRE
Core One Labs Begins Trading On OTCQB
Via Benzinga
Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.